documents: FDA-1998-N-1290-0003
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1998-N-1290-0003 | FDA | FDA-1998-N-1290 | Agency Information Collection Activities; Announcement of OMB Approval; New Drug and Biological Drug Products; Evidence Needed to Demonstrate Efficacy of New Drugs for Use Against Lethal or Permanently Disabling Toxic Substances When Efficacy Studies in Humans Ethically Cannot Be Conducted | Notice | NAL-Notice of Approval | 2009-04-23T04:00:00Z | 2009 | 4 | 2009-04-23T04:00:00Z | 2009-04-24T00:57:15Z | 00–991 | 0 | 0 | 09000064805a6f3c |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref